Taken together, our findings provide significant data to propose a model for investigating the role of RASSF1C/MEK-ERK1/2 pathway in initiation and progression of lung cancer cells in vitro and in vivo (Figure 8). The gene discussed is MAPK3; the disease is lung carcinoma.